Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Vanessa Schneider, Stephanie Egenrieder, Marlies Götz, Cornelia Herbst, Jochen Greiner & Susanne Hofmann. (2013) Specific immune responses against epitopes derived from Aurora kinase A and B in acute myeloid leukemia. Leukemia & Lymphoma 54:7, pages 1500-1504.
Read now
Read now
Articles from other publishers (15)
Dayong Zheng, Jun Li, Han Yan, Gang Zhang, Wei Li, Edward Chu & Ning Wei. (2023) Emerging roles of Aurora-A kinase in cancer therapy resistance. Acta Pharmaceutica Sinica B 13:7, pages 2826-2843.
Crossref
Crossref
Ya Guo, Yin Bin Zhang, Yi Li, Wang Hui Su, Shan He, Shu Pei Pan, Kun Xu & Wei Hua Kou. (2022) Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma. International Journal of Genomics 2022, pages 1-35.
Crossref
Crossref
Nicholas McConnell, Zhigang Xu, Vishnu Kumarasamy, Daekyu Sun, Brendan Frett & Hong-yu Li. (2017) Synthesis of Constrained Heterocycles Employing Two Post-Ugi Cyclization Methods for Rapid Library Generation with In Cellulo Activity. ChemistrySelect 2:35, pages 11821-11825.
Crossref
Crossref
Vladislav KorobeynikovAlexander Y. Deneka & Erica A. Golemis. (2017) Mechanisms for nonmitotic activation of Aurora-A at cilia. Biochemical Society Transactions 45:1, pages 37-49.
Crossref
Crossref
He Cui, Xi Lan, Shemin Lu, Fujun Zhang & Wanggang Zhang. (2017) Bioinformatic prediction and functional characterization of human KIAA0100 gene. Journal of Pharmaceutical Analysis 7:1, pages 10-18.
Crossref
Crossref
Keith J. August, Aru Narendran & Kathleen A. Neville. (2013) Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions. Drugs 73:5, pages 439-461.
Crossref
Crossref
Yi-Yu Ke, Hui-Yi Shiao, Yung Chang Hsu, Chang-Ying Chu, Wen-Chieh Wang, Yen-Chun Lee, Wen-Hsing Lin, Chun-Hwa Chen, John T. A. Hsu, Chun-Wei Chang, Cheng-Wei Lin, Teng-Kuang Yeh, Yu-Sheng Chao, Mohane Selvaraj Coumar & Hsing-Pang Hsieh. (2013) 3D-QSAR-Assisted Drug Design: Identification of a Potent Quinazoline-Based Aurora Kinase Inhibitor. ChemMedChem 8:1, pages 136-148.
Crossref
Crossref
Harshani R. Lawrence, Mathew P. Martin, Yunting Luo, Roberta Pireddu, Hua Yang, Harsukh Gevariya, Sevil Ozcan, Jin-Yi Zhu, Robert Kendig, Mercedes Rodriguez, Roy Elias, Jin Q. Cheng, Saïd M. Sebti, Ernst Schonbrunn & Nicholas J. Lawrence. (2012)
Development of
o
-Chlorophenyl Substituted Pyrimidines as Exceptionally Potent Aurora Kinase Inhibitors
. Journal of Medicinal Chemistry 55:17, pages 7392-7416.
Crossref
Crossref
Takashi Mori, Satoshi Nishizawa, Yoshihiko Hirohashi, Toshihiko Torigoe, Yasuaki Tamura, Akari Takahashi, Vitaly Kochin, Reona Fujii, Toru Kondo, Mark I. Greene, Isao Hara & Noriyuki Sato. (2012) Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population. Experimental and Molecular Pathology 92:1, pages 27-32.
Crossref
Crossref
Katayoun Rezvani. (2012) Aurora: a new direction for a new dawn. Blood 119:2, pages 322-323.
Crossref
Crossref
Mark G. Manfredi, Jeffrey A. Ecsedy, Arijit Chakravarty, Lee Silverman, Mengkun Zhang, Kara M. Hoar, Stephen G. Stroud, Wei Chen, Vaishali Shinde, Jessica J. Huck, Deborah R. Wysong, David A. Janowick, Marc L. Hyer, Patrick J. LeRoy, Rachel E. Gershman, Matthew D. Silva, Melissa S. Germanos, Joseph B. Bolen, Christopher F. Claiborne & Todd B. Sells. (2011)
Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel
In Vivo
Pharmacodynamic Assays
. Clinical Cancer Research 17:24, pages 7614-7624.
Crossref
Crossref
Chang-Tze Ricky Yu, Jiun-Yi Hsia, Yun-Chih Hseih, Li-Jen Su, Tien-Chiang Lee, Chia-Feng Ku, Ke-Shin Chen, Jou-May Maureen Chen, Tong-You Wade Wei, Yuan-Chii Gladys Lee, Chi-Ying F. Huang, Yu-Chung Wu, Chiou-Ying Yang & Shih-Lan Hsu. (2011) The Novel Protein Suppressed in Lung Cancer Down-Regulated in Lung Cancer Tissues Retards Cell Proliferation and Inhibits the Oncokinase Aurora-A. Journal of Thoracic Oncology 6:6, pages 988-997.
Crossref
Crossref
Jianyong Xu, Huapeng Li, Bo Wang, Yan Xu, Jiayin Yang, Xiaofei Zhang, Sarah K. Harten, Deepa Shukla, Patrick H. Maxwell, Duanqing Pei & Miguel A. Esteban. (2010) VHL Inactivation Induces HEF1 and Aurora Kinase A. Journal of the American Society of Nephrology 21:12, pages 2041-2046.
Crossref
Crossref
Georgios Giamas, Yik L. Man, Heidrun Hirner, Joachim Bischof, Klaus Kramer, Kalimullah Khan, Sharmeen S. Lavina Ahmed, Justin Stebbing & Uwe Knippschild. (2010) Kinases as targets in the treatment of solid tumors. Cellular Signalling 22:7, pages 984-1002.
Crossref
Crossref
Toshiki Ochi, Hiroshi Fujiwara & Masaki Yasukawa. (2010) Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia. Journal of Biomedicine and Biotechnology 2010, pages 1-10.
Crossref
Crossref